Abstract: The disclosure belongs to a field of hydraulic equipment, and in particular to an anti-rolling damping device for floating wind turbines. The specific technical scheme: low ends of buoys are connected with an upper surface of a support plate through a damping assembly, and the damping assembly includes a piston cylinder fixedly arranged on the support plate, a piston plate is slidably arranged in the piston cylinder, a piston rod is arranged at one end of the piston plate far from the support plate, the piston rod extends out of the piston cylinder and is fixedly connected with the buoys, and a plurality of first through holes are arranged on a side wall of the piston cylinder near the lower part. The buoys sink with waves, and the piston plate slides downwards in the piston cylinder.

Abstract: Disclosed is a method for optimization design of an artificial reef structure. The method includes: arranging an artificial reef model to be tested on a test platform, testing a flow field to obtain flow field data and a pull force of an artificial reef, analyzing the flow field data to obtain a flow velocity reference point, and carrying out optimization analysis in combination with the flow field data and the pull force.

Abstract: The disclosure belongs to a field of hydraulic equipment, and in particular to an anti-rolling damping device for floating wind turbines. The specific technical scheme: low ends of buoys are connected with an upper surface of a support plate through a damping assembly, and the damping assembly includes a piston cylinder fixedly arranged on the support plate, a piston plate is slidably arranged in the piston cylinder, a piston rod is arranged at one end of the piston plate far from the support plate, the piston rod extends out of the piston cylinder and is fixedly connected with the buoys, and a plurality of first through holes are arranged on a side wall of the piston cylinder near the lower part. The buoys sink with waves, and the piston plate slides downwards in the piston cylinder.

Abstract: A forming powder for a forming part with a low tensile anisotropy by additive manufacturing, which can be used for forming the forming part with low tensile anisotropy, a method for forming a forming part with a low tensile anisotropy, and a forming part with a low tensile anisotropy. The forming powder for the forming part with low tensile anisotropy by additive manufacturing includes the following chemical components in terms of mass percentage (wt-%): 0.03%?C?0.09%, 20.50%?Cr?23.00%, 0.50%?Co?2.50%, 8.00%?Mo?10.00%, 0.20%?W?1.00%, 17.00%?Fe?20.00%, 0%<B<0.001%, 0%?Mn?1.00%, 0%?Si?0.15%, 0%?O?0.02%, 0%?N?0.015%, the rest are Ni and inevitable impurities.

Abstract: A non-destructive testing method for lack-of-fusion (LOF) defects, and a testing standard part and a manufacturing method thereof, used for the non-destructive testing of LOF defects of an additive manufacturing workpiece. The manufacturing method of the LOF defect standard part comprises: step A, setting a LOF defect area of the standard part, in the LOF defect area, a proportion of the LOF defects in the LOF defect area is set as a first proportion value; step B, selecting an additive manufacturing forming process for manufacturing the LOF defect area to obtain a first process parameter of the additive manufacturing forming process corresponding to the first proportion value; step C, performing the additive manufacturing forming process based on the first process parameter to form the LOF defect area.

Abstract: A method for prefabricating pore defects by controlling a SLM process, including performing laser scanning on a specified metal melt layer (LY) according to a first scan path (P1) and a second scan path. The first scan path (P1) and the second scan path (P2) have a path overlap zone (A0), the path overlap zone (A0) has a predetermined width, and laser energy input superimposed in the path overlap zone (A0) is controlled to reach a predetermined energy value, whereby keyholes are formed at a plurality of positions in a lengthwise direction of the path overlap zone (A0), the specified metal melt layer (LY) is taken as a defect layer, and the keyholes in the path overlap zone (A0) is taken as pore defects.

Abstract: A preparation method for a metal-modified SAPO molecular sieve is disclosed, characterized in adding a raw powder of the SAPO molecular sieve to a solution containing metal ions for performing ion exchange, and then washing and drying the obtained solid after ion exchange, so as to obtain the metal-modified SAPO molecular sieve. The metal-modified SAPO molecular sieve prepared has a relatively high degree of crystallinity, and the metal elements occupy the ionic positions in the channels and/or cages of the SAPO molecular sieve, and the metal-modified SAPO molecular sieve shows excellent catalytic performance in the catalytic reaction.

Abstract: A preparation method for a metal-modified SAPO molecular sieve is disclosed, characterized in adding a raw powder of the SAPO molecular sieve to a solution containing metal ions for performing ion exchange, and then washing and drying the obtained solid after ion exchange, so as to obtain the metal-modified SAPO molecular sieve. The metal-modified SAPO molecular sieve prepared has a relatively high degree of crystallinity, and the metal elements occupy the ionic positions in the channels and/or cages of the SAPO molecular sieve, and the metal-modified SAPO molecular sieve shows excellent catalytic performance in the catalytic reaction.

Abstract: The present invention relates to a method for preparation of heparin silver, to use of heparin silver in manufacture of medicine for treating burns and/or scalds, to a method of using heparin silver to treat burns and/or scalds, and to a topical preparation containing heparin silver for treating burns and/or scalds. The heparin silver product prepared according to the method of the present invention has a high purity and less impurity. The animal test proved that the medicine made by using heparin silver exhibited effects of accelerating wound healing and reducing scar formation.

Abstract: The present invention discloses a bismuth hyaluronate, characterized in that the bismuth content is from 0.5% to 40%, and the glucuronate content is from 20% to 45%, based on dry weight. Also provided is a method for the preparation of said bismuth hyaluronate comprising reaction of a soluble hyaluronate salt with a bismuth salt in a basic aqueous solution, followed by steps of precipitation, filtration, desalting, dehydrating and drying to obtain the product. Further disclosed is the use of the bismuth hyaluronate in the manufacture of a medicament or health foods for preventing and treating gastrointestinal disorders, in particular ulcerous disorders of the GI tract. It has been proven in animal experiments to show a better therapeutic effect than products of the same type.

Abstract: The present invention discloses a bismuth hyaluronate, characterized in that the bismuth content is from 0.5% to 40%, and the glucuronate content is from 20% to 45%, based on dry weight. Also provided is a method for the preparation of said bismuth hyaluronate comprising reaction of a soluble hyaluronate salt with a bismuth salt in a basic aqueous solution, followed by steps of precipitation, filtration, desalting, dehydrating and drying to obtain the product. Further disclosed is the use of the bismuth hyaluronate in the manufacture of a medicament or health foods for preventing and treating gastrointestinal disorders, in particular ulcerous disorders of the GI tract. It has been proven in animal experiments to show a better therapeutic effect than products of the same type.

Abstract: The present invention relates to a method for preparation of heparin silver, to use of heparin silver in manufacture of medicine for treating burns and/or scalds, to a method of using heparin silver to treat burns and/or scalds, and to a topic topical preparation containing heparin silver for treating burns and/or scalds. The heparin silver product prepared according to the method of the present invention has a high purity and less impurity. The animal test proved that the medicine made by using heparin silver exhibited effects of accelerating wound healing and reducing scar formation.